{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:42:15Z","timestamp":1769233335955,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NSERC Undergraduate Student Research Award"},{"name":"National Sciences and Engineering Research Council of Canada Discovery Grants","award":["RGPIN-2019-05038"],"award-info":[{"award-number":["RGPIN-2019-05038"]}]},{"name":"National Sciences and Engineering Research Council of Canada Alliance Grant","award":["ALLRP 557112-20"],"award-info":[{"award-number":["ALLRP 557112-20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Radiobiological indices can provide insights into treatment efficacy beyond traditional physical dose metrics and potentially facilitate the comparison between various radiotherapy plans. This study investigates the integration of radiobiological indices with standard physical dose criteria to improve high-dose-rate (HDR) brachytherapy plan evaluation and selection process for the treatment of prostate cancers in a multicriteria optimization (MCO) framework. This is accomplished within the framework of a graphics processing unit-based multicriteria optimization algorithm, gMCO. 2000 Pareto-optimal plans for 200 patients were optimized for a 15 Gy HDR brachytherapy boost after external beam radiation therapy (44 Gy in 22 fractions). Tumour control probability (TCP), normal tissue complication probability (NTCP), and uncomplicated tumour control probability (UTCP) were calculated for each plan. Maximizing UTCP alone resulted in insufficient target coverage (target\n                    <jats:inline-formula>\n                      <jats:tex-math>$$V_{100} &lt; 90\\%$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    ) according to clinical guidelines. Conversely, maximizing target coverage while meeting institutional criteria compromised UTCP significantly (reduction of about 0.09). Selecting plans that met all institutional criteria first, then maximizing UTCP, achieved a balanced compromise between tumour control and normal tissue safety. While combining UTCP and standard dose metrics based on dose-volume histogram (i.e., absorbed dose or physical dose constraints) with MCO can enhance brachytherapy plan optimization, exclusive reliance on standard TCP and NTCP models, using recommended parameters, yields clinically unacceptable plans.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-32494-w","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:02:58Z","timestamp":1768827778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective evaluation of high-dose-rate brachytherapy multicriteria planning using physical dose versus radiobiological criteria for prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Charles","family":"Iorio-Duval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"B\u00e9langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Vigneault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"32494_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semradonc.2019.08.009","volume":"30","author":"P Annede","year":"2020","unstructured":"Annede, P. et al. Radiobiology: Foundation and new insights in modeling brachytherapy effects. Semin. Radiat. Oncol. 30, 4\u201315 (2020).","journal-title":"Semin. Radiat. Oncol."},{"key":"32494_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.brachy.2019.04.005","volume":"18","author":"CJ Tien","year":"2019","unstructured":"Tien, C. J., Carlson, D. J., Nath, R. & Chen, Z. J. High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay. Brachytherapy 18, 701\u2013710 (2019).","journal-title":"Brachytherapy"},{"key":"32494_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0360-3016(95)00162-R","volume":"33","author":"SP Lee","year":"1995","unstructured":"Lee, S. P. et al. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int. J. Radiat. Oncol. Biol. Phys. 33, 375\u2013389 (1995).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.semradonc.2019.09.001","volume":"30","author":"JAM Cunha","year":"2020","unstructured":"Cunha, J. A. M. et al. Brachytherapy future directions. Semin. Radiat. Oncol. 30, 94\u2013106 (2020).","journal-title":"Semin. Radiat. Oncol."},{"key":"32494_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.meddos.2011.11.004","volume":"37","author":"LC Holloway","year":"2012","unstructured":"Holloway, L. C. et al. Comp Plan: A computer program to generate dose and radiobiological metrics from dose-volume histogram files. Med. Dosim. 37, 305\u2013309 (2012).","journal-title":"Med. Dosim."},{"key":"32494_CR6","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1002\/mp.17062","volume":"51","author":"ZJ Chen","year":"2024","unstructured":"Chen, Z. J. et al. AAPM task group report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy. Med. Phys. 51, 3850\u20133923 (2024).","journal-title":"Med. Phys."},{"key":"32494_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"JF Fowler","year":"1989","unstructured":"Fowler, J. F. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62, 679\u2013694 (1989).","journal-title":"Br. J. Radiol."},{"key":"32494_CR8","doi-asserted-by":"publisher","first-page":"01TR01","DOI":"10.1088\/1361-6560\/aaf26a","volume":"64","author":"SJ McMahon","year":"2018","unstructured":"McMahon, S. J. The linear quadratic model: Usage, interpretation and challenges. Phys. Med. Biol. 64, 01TR01 (2018).","journal-title":"Phys. Med. Biol."},{"key":"32494_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0360-3016(02)04282-7","volume":"55","author":"Z Chen","year":"2003","unstructured":"Chen, Z. & Nath, R. Biologically effective dose (BED) for interstitial seed implants containing a mixture of radionuclides with different half-lives. Int. J. Radiat. Oncol. Biol. Phys. 55, 825\u2013834 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"32494_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.brachy.2023.03.003","volume":"22","author":"CJ Tien","year":"2023","unstructured":"Tien, C. J. & Chen, Z. Radiobiological evaluation of the stepping-source effect in single-fraction monotherapy high-dose-rate prostate brachytherapy. Brachytherapy 22(5), 593\u2013606 (2023).","journal-title":"Brachytherapy"},{"key":"32494_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","volume":"21","author":"C Burman","year":"1991","unstructured":"Burman, C., Kutcher, G. J., Emami, B. & Goitein, M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21, 123\u2013135 (1991).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR12","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks, L. B. et al. Use of normal tissue complication probability models in the clinic. Int. J. Radiat. Oncol. Biol. Phys. 76, S10\u2013S19 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR13","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","volume":"76","author":"JM Michalski","year":"2010","unstructured":"Michalski, J. M. et al. Radiation dose\u2014Volume effects in radiation-induced rectal injury. Int. J. Radiat. Oncol. Biol. Phys. 76, S123\u2013S129 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR14","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab1817","volume":"64","author":"C B\u00e9langer","year":"2019","unstructured":"B\u00e9langer, C. et al. A GPU-based multi-criteria optimization algorithm for HDR brachytherapy. Phys. Med. Biol. 64, 105005 (2019).","journal-title":"Phys. Med. Biol."},{"key":"32494_CR15","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1002\/mp.13681","volume":"46","author":"A Bouter","year":"2019","unstructured":"Bouter, A. et al. GPU-accelerated bi-objective treatment planning for prostate high-dose-rate brachytherapy. Med. Phys. 46, 3776\u20133787 (2019).","journal-title":"Med. Phys."},{"issue":"20","key":"32494_CR16","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab44ff","volume":"64","author":"S Breedveld","year":"2019","unstructured":"Breedveld, S. et al. Fast automated multi-criteria planning for HDR brachytherapy explored for prostate cancer. Phys. Med. Biol. 64(20), 205002 (2019).","journal-title":"Phys. Med. Biol."},{"key":"32494_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.brachy.2020.06.016","volume":"19","author":"C B\u00e9langer","year":"2020","unstructured":"B\u00e9langer, C. et al. Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapy. Brachytherapy 19, 607\u2013617 (2020).","journal-title":"Brachytherapy"},{"issue":"4","key":"32494_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.brachy.2020.02.013","volume":"19","author":"CL Deufel","year":"2020","unstructured":"Deufel, C. L. et al. PNaV: A tool for generating a high-dose-rate brachytherapy treatment plan by navigating the Pareto surface guided by the visualization of multidimensional trade-offs. Brachytherapy 19(4), 518\u201353 (2020).","journal-title":"Brachytherapy"},{"key":"32494_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.radonc.2020.04.017","volume":"148","author":"M Oud","year":"2020","unstructured":"Oud, M. et al. Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer. Radiother. Oncol. 148, 143\u2013150 (2020).","journal-title":"Radiother. Oncol."},{"key":"32494_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.brachy.2022.04.003","volume":"21","author":"C B\u00e9langer","year":"2022","unstructured":"B\u00e9langer, C. et al. Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy. Brachytherapy 21, 551\u2013560 (2022).","journal-title":"Brachytherapy"},{"key":"32494_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.brachy.2022.11.013","volume":"22","author":"DL Barten","year":"2023","unstructured":"Barten, D. L. et al. Towards artificial intelligence-based automated treatment planning in clinical practice: A prospective study of the first clinical experiences in high-dose-rate prostate brachytherapy. Brachytherapy 22, 279\u2013289 (2023).","journal-title":"Brachytherapy"},{"key":"32494_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.radonc.2017.06.012","volume":"124","author":"E Vigneault","year":"2017","unstructured":"Vigneault, E. et al. High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes. Radiother. Oncol. 124, 49\u201355 (2017).","journal-title":"Radiother. Oncol."},{"key":"32494_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1118\/1.1368127","volume":"28","author":"E Lessard","year":"2001","unstructured":"Lessard, E. & Pouliot, J. Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med. Phys. 28, 773\u2013779 (2001).","journal-title":"Med. Phys."},{"key":"32494_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0167-8140(93)90239-5","volume":"29","author":"A Niemierko","year":"1993","unstructured":"Niemierko, A. & Goitein, M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother. Oncol. 29, 140\u2013147 (1993).","journal-title":"Radiother. Oncol."},{"key":"32494_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1088\/0031-9155\/38\/6\/001","volume":"38","author":"S Webb","year":"1993","unstructured":"Webb, S. & Nahum, A. E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys. Med. Biol. 38, 653 (1993).","journal-title":"Phys. Med. Biol."},{"key":"32494_CR26","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1118\/1.3246613","volume":"36","author":"R Nath","year":"2009","unstructured":"Nath, R. et al. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137. Med. Phys. 36, 5310\u20135322 (2009).","journal-title":"Med. Phys."},{"key":"32494_CR27","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2307\/3583506","volume":"8","author":"JT Lyman","year":"1985","unstructured":"Lyman, J. T. Complication probability as assessed from dose-volume histograms. Radiat. Res. Suppl. 8, S13-19 (1985).","journal-title":"Radiat. Res. Suppl."},{"key":"32494_CR28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","volume":"16","author":"GJ Kutcher","year":"1989","unstructured":"Kutcher, G. J. & Burman, C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method Gerald. Int. J. Radiat. Oncol. Biol. Phys. 16, 1623\u20131630 (1989).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13014-018-0961-x","volume":"13","author":"P Mavroidis","year":"2018","unstructured":"Mavroidis, P. et al. Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy. Radiat. Oncol. 13, 17 (2018).","journal-title":"Radiat. Oncol."},{"key":"32494_CR30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fonc.2020.00910","volume":"10","author":"V Panettieri","year":"2020","unstructured":"Panettieri, V. et al. External validation of a predictive model of urethral strictures for prostate patients treated with HDR brachytherapy boost. Front. Oncol. 10, 910 (2020).","journal-title":"Front. Oncol."},{"key":"32494_CR31","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1118\/1.3481514","volume":"37","author":"R Takam","year":"2010","unstructured":"Takam, R., Bezak, E., Yeoh, E. E. & Marcu, L. Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models. Med. Phys. 37, 5126\u20135137 (2010).","journal-title":"Med. Phys."},{"key":"32494_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijrobp.2013.10.016","volume":"88","author":"P Mavroidis","year":"2014","unstructured":"Mavroidis, P. et al. Comparison of different fractionation schedules toward a single fraction in high-dose-rate brachytherapy as monotherapy for low-risk prostate cancer using 3-dimensional radiobiological models. Int. J. Radiat. Oncol. Biol. Phys. 88, 216\u2013223 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100739","volume":"6","author":"ML Cheung","year":"2021","unstructured":"Cheung, M. L. et al. Analysis of hepatocellular carcinoma stereotactic body radiation therapy dose prescription method using uncomplicated tumor control probability model. Adv. Radiat. Oncol. 6, 100739 (2021).","journal-title":"Adv. Radiat. Oncol."},{"key":"32494_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","volume":"43","author":"DJ Brenner","year":"1999","unstructured":"Brenner, D. J. & Hall, E. J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 43, 1095\u20131101 (1999).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","volume":"55","author":"JZ Wang","year":"2003","unstructured":"Wang, J. Z., Guerrero, M. & Li, X. A. How low is the alpha\/beta ratio for prostate cancer?. Int. J. Radiat. Oncol. Biol. Phys. 55, 194\u2013203 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.radonc.2021.12.047","volume":"167","author":"A Henry","year":"2022","unstructured":"Henry, A., Pieters, B. R., Andr\u00e9 Siebert, F. & Hoskin, P. GEC-ESTRO ACROP prostate brachytherapy guidelines. Radiother. Oncol. 167, 244\u2013251 (2022).","journal-title":"Radiother. Oncol."},{"key":"32494_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijrobp.2009.10.035","volume":"79","author":"AA Martinez","year":"2011","unstructured":"Martinez, A. A. et al. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 79, 363\u2013370 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32494_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","volume":"18","author":"JP Kirkpatrick","year":"2008","unstructured":"Kirkpatrick, J. P., Meyer, J. J. & Marks, L. B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin. Radiat. Oncol. 18, 240\u2013243 (2008).","journal-title":"Semin. Radiat. Oncol."},{"key":"32494_CR39","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.3390\/cancers15143659","volume":"15","author":"J Pardo-Montero","year":"2023","unstructured":"Pardo-Montero, J., Gonz\u00e1lez-Crespo, I., G\u00f3mez-Caama\u00f1o, A. & Gago-Arias, A. Radiobiological meta-analysis of the response of prostate cancer to different fractionations: Evaluation of the linear-quadratic response at large doses and the effect of risk and adt. Cancers 15, 3659 (2023).","journal-title":"Cancers"},{"key":"32494_CR40","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1111\/cas.15796","volume":"114","author":"H Li","year":"2023","unstructured":"Li, H. Invalidity of, and alternative to, the linear quadratic model as a predictive model for postirradiation cell survival. Cancer Sci. 114, 2931\u20132938 (2023).","journal-title":"Cancer Sci."},{"key":"32494_CR41","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/mp.17550","volume":"52","author":"PY Chatigny","year":"2025","unstructured":"Chatigny, P. Y., B\u00e9langer, C., Poulin, E. & Beaulieu, L. Automatic plan selection using deep network-a prostate study. Med. Phys. 52, 1717\u20131727 (2025).","journal-title":"Med. Phys."},{"key":"32494_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.radonc.2007.06.010","volume":"84","author":"C Kirisits","year":"2007","unstructured":"Kirisits, C. et al. Accuracy of volume and dvh parameters determined with different brachytherapy treatment planning systems. Radiother. Oncol. 84, 290\u2013297 (2007).","journal-title":"Radiother. Oncol."},{"key":"32494_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/acm2.12563","volume":"20","author":"MC van der Meer","year":"2019","unstructured":"van der Meer, M. C. et al. Sensitivity of dose-volume indices to computation settings in high-dose-rate prostate brachytherapy treatment plan evaluation. J. Appl. Clin. Med. Phys. 20, 66\u201374 (2019).","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"32494_CR44","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/abe04e","volume":"66","author":"MCVD Meer","year":"2021","unstructured":"Meer, M. C. V. D. et al. Robust optimization for HDR prostate brachytherapy applied to organ reconstruction uncertainty. Phys. Med. Biol. 66, 055001 (2021).","journal-title":"Phys. Med. Biol."},{"key":"32494_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semradonc.2017.11.005","volume":"28","author":"J Unkelbach","year":"2018","unstructured":"Unkelbach, J. & Paganetti, H. Robust proton treatment planning: Physical and biological optimization. Semin. Radiat. Oncol. 28, 88\u201396 (2018).","journal-title":"Semin. Radiat. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32494-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:09:39Z","timestamp":1769213379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32494-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32494"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32494-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2561"}}